This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Assistance Publique-Hopitaux De Paris, Ecole Centrale De Lyon, Université De Paris. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2024
Title: Jean-Charles Auregan: Innovator in Non-Invasive Tissue Evaluation
Introduction
Jean-Charles Auregan is a notable inventor based in Paris, France. He has made significant contributions to the field of medical technology, particularly in the evaluation of connective tissues. His innovative approach focuses on non-invasive methods that enhance patient care and diagnostics.
Latest Patents
Auregan holds a patent for a non-invasive process for the evaluation of the quality of internal dense connective tissues. This invention involves analyzing the microrelief profile of a cutaneous replica of a patient's skin. The process includes visually assessing the line shape and anisotropy of the lines, as well as determining the roughness index of the microrelief using an optical sensor. The method identifies healthy and altered skin stages, providing valuable insights into the quality of dense connective tissues in patients.
Career Highlights
Throughout his career, Jean-Charles Auregan has worked with esteemed institutions such as École Centrale de Lyon and Assistance Publique-Hôpitaux de Paris. His work has been instrumental in advancing non-invasive diagnostic techniques, which are crucial for improving patient outcomes.
Collaborations
Auregan has collaborated with notable professionals in his field, including Thierry Hoc and Morad Bensidhoum. These partnerships have contributed to the development and refinement of his innovative processes.
Conclusion
Jean-Charles Auregan's contributions to non-invasive tissue evaluation represent a significant advancement in medical diagnostics. His work not only enhances the understanding of connective tissue quality but also paves the way for improved patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile